tiprankstipranks
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
US Market

OKYO Pharma Limited Sponsored ADR (OKYO) Financial Statements

31 Followers

OKYO Pharma Limited Sponsored ADR Financial Overview

OKYO Pharma Limited Sponsored ADR's market cap is currently ―. The company's EPS TTM is $-0.006; its P/E ratio is -217.91; OKYO Pharma Limited Sponsored ADR is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Mar 22Sep 21Mar 21Sep 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 633.63K£ 2.70M£ 3.85M£ 4.99M£ 5.76M
Total Assets£ 1.59M£ 4.30M£ 4.18M£ 5.14M£ 5.84M
Total Debt£ 0.00£ 0.00£ 60.73K£ 71.56K£ 22.52K
Net Debt£ -633.63K£ -2.70M£ -3.79M£ -4.92M£ -5.74M
Total Liabilities£ 1.90M£ 1.35M£ 494.83K£ 1.28M£ 342.75K
Stockholders Equity£ -309.68K£ 2.95M£ 3.68M£ 3.85M£ 5.50M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

OKYO Pharma Limited Sponsored ADR Earnings and Revenue History

OKYO Pharma Limited Sponsored ADR Debt to Assets

OKYO Pharma Limited Sponsored ADR Cash Flow

OKYO Pharma Limited Sponsored ADR Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis